Lv1
2 积分 2026-10-19 加入
The GPR40 novel agonist SZZ15 ‐11 improves non‐alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet‐induced obese mice
3小时前
待确认
AMPK activation by SC4 inhibits noradrenaline-induced lipolysis and insulin-stimulated lipogenesis in white adipose tissue
4小时前
已完结
Sensing of Long-Chain Fatty Acyl-CoA Esters by AMPK
5小时前
已完结
Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis
5小时前
已完结
皖公网安备34019202002308
